D-1334-2022 Class III Terminated

Recalled by Teva Pharmaceuticals USA Inc — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
August 17, 2022
Initiation Date
July 22, 2022
Termination Date
April 12, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4162 cartons

Product Description

Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56

Reason for Recall

Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.

Distribution Pattern

Distributed in Ohio

Code Information

Lot: FE22001A, Exp 01/2024